|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.48 USD | +2.51% |
|
+9.97% | +26.61% |
| 06-10 | CVS Will Pay $36.5 Million to Settle Insulin Fraud Claims With State AGs, DOJ | DJ |
| 06-08 | UBS Adjusts Price Target on CVS Health to $115 From $100, Maintains Buy Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 104.5 | +6.61% | 26 | |||||||
| 503.57 | +34.88% | 21 | |||||||
| 54.79 | +45.38% | 14 | |||||||
| 223.44 | +9.65% | 16 | |||||||
| 274.11 | +27.73% | 14 | |||||||
| 243.62 | +47.85% | 21 | |||||||
| 48.75 | +49.99% | 13 | |||||||
| 193.71 | -2.43% | 7 | |||||||
| 44.04 | +13.41% | 17 | |||||||
| 1,148.52 | +13.7% | 25 | |||||||
| 215.76 | +48.99% | 17 | |||||||
| - | - | - | - | - | |||||
| 446.5 | +2.78% | 4 | |||||||
| 49.17 | +43.22% | 6 | |||||||
| 20.11 | +23.61% | 9 | |||||||
| 201.55 | +14.51% | 22 | |||||||
| 23.73 | +23.04% | 6 | |||||||
| 31.5 | +18.38% | 8 | |||||||
| 28.58 | +33.69% | 12 | |||||||
| 825.62 | +8.19% | 16 | |||||||
| Average | 246.4 | +24.38% | 14 | ||||||
| Weighted average by Cap. | 247.75 | +22.02% | 20 |
- Stock Market
- Stocks
- CVS Stock
- Sector CVS Health Corporation
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















